ArticleCancer immunology, immunotherapy : CII2024

NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity.

Aurelie Herault et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.